Literature DB >> 8202026

Reactivity of varicella-zoster virus subunit antigens in enzyme-linked immunosorbent assay to sera from varicella, zoster, and herpes simplex virus infections.

M Takayama1.   

Abstract

Serological responses to varicella-zoster virus (VZV) subunit antigens, such as capsid, envelope, and soluble (S) antigens, in patients with VZV and herpes simplex virus (HSV) infections were studied by comparing with responses to virion (V) antigens using an enzyme-linked immunosorbent assay (ELISA). S antigen, prepared by concentrating supernatant of VZV or HSV type 1 (HSV-1)-infected cell culture fluid, reacted strongly to sera from patients with secondary infection but reacted poorly to those from patients with a primary infection of VZV or HSV. Antibody titers to VZV-S antigen persisted for a long period in patients with VZV infections. Patients infected with VZV showed antibody increase to HSV-1, when tested by complement fixation or complement-enhanced neutralization test, in cases with a history of prior HSV infection. However, such a cross-reaction was only observed to a minor extent in ELISA test using S antigen. S antigen reaction was stronger in secondary infections in tests with various subunit antigens. Almost no cross-reactivity was observed in an immunoblotting test with S antigen. Differentiation between infections with either varicella or zoster or HSV can be made by comparison of antibody responses to V and S antigens.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8202026     DOI: 10.1007/bf00193626

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  20 in total

1.  Specificity of skin test with varicella-zoster virus antigen in varicella-zoster and herpes simplex virus infections.

Authors:  K Baba; K Shiraki; T Kanesaki; K Yamanishi; P L Ogra; H Yabuuchi; M Takahashi
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

2.  Comparative assay of varicella skin test antigens by the ELISA and RPHA tests.

Authors:  K Shiraki; T Okuno; T Kato; K Yamanishi; M Takahashi
Journal:  Acta Virol       Date:  1990-04       Impact factor: 1.162

3.  Western blot analysis poorly detects antibody to gpIII of Varicella-Zoster virus.

Authors:  L Dubey; C A Gabel; A Gershan
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

4.  Purification of individual varicella-zoster virus (VZV) glycoproteins gpI, gpII, and gpIII and their use in ELISA for detection of VZV glycoprotein-specific antibodies.

Authors:  P M Keller; K Lonergan; B J Neff; D A Morton; R W Ellis
Journal:  J Virol Methods       Date:  1986-09       Impact factor: 2.014

5.  Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization and fluorescent antibody tests.

Authors:  N J Schmidt; E H Lennette; R L Magoffin
Journal:  J Gen Virol       Date:  1969-04       Impact factor: 3.891

6.  HSV-1 gB and VZV gp-II crossreactive antibodies in human sera.

Authors:  J E Kühn; K Klaffke; K Munk; R W Braun
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

7.  Antibodies against varicella-zoster virus and herpes simplex virus deoxythymidine kinase in heterologous infections.

Authors:  C F Källander; E G Torfason; E Olding-Stenkvist; V A Sundqvist; H Diderholm; J S Gronowitz
Journal:  J Med Virol       Date:  1989-05       Impact factor: 2.327

8.  Complement-fixing reactivity of Varicella-Zoster virus subunit antigens with sera from homotypic infections and heterotypic Herpes simplex virus infections.

Authors:  N J Schmidt; J Dennis; E H Lennette
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

9.  Western blot analysis of antibody to varicella-zoster virus.

Authors:  L Dubey; S P Steinberg; P LaRussa; P Oh; A A Gershon
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

10.  Synthesis and processing of glycoproteins of Varicella-Zoster virus (VZV) as studied with monoclonal antibodies to VZV antigens.

Authors:  T Okuno; K Yamanishi; K Shiraki; M Takahashi
Journal:  Virology       Date:  1983-09       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.